David P. Dearnaley

1981–2025 年に発表

別表記
David P Dearnaley
171
論文数
32,825
被引用数
100
h 指数
171
i10 指数

被引用数

David P. Dearnaley の年別被引用数1896 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 5 件1984 年: 被引用 4 件1985 年: 被引用 8 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 10 件1992 年: 被引用 8 件1993 年: 被引用 10 件1994 年: 被引用 16 件1995 年: 被引用 15 件1996 年: 被引用 18 件1997 年: 被引用 29 件1998 年: 被引用 27 件1999 年: 被引用 41 件2000 年: 被引用 40 件2001 年: 被引用 76 件2002 年: 被引用 71 件2003 年: 被引用 78 件2004 年: 被引用 64 件2005 年: 被引用 89 件2006 年: 被引用 89 件2007 年: 被引用 111 件2008 年: 被引用 126 件2009 年: 被引用 178 件2010 年: 被引用 228 件2011 年: 被引用 285 件2012 年: 被引用 225 件2013 年: 被引用 272 件2014 年: 被引用 249 件2015 年: 被引用 243 件2016 年: 被引用 233 件2017 年: 被引用 207 件2018 年: 被引用 322 件2019 年: 被引用 891 件2020 年: 被引用 923 件2021 年: 被引用 886 件2022 年: 被引用 638 件2023 年: 被引用 449 件2024 年: 被引用 715 件2025 年: 被引用 350 件2026 年: 被引用 17 件1897〜1981 年は被引用が無いため表示していません1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,499 件、この内訳の 21.9%イギリス: 引用元論文 1,283 件、この内訳の 11.2%カナダ: 引用元論文 657 件、この内訳の 5.8%ドイツ: 引用元論文 629 件、この内訳の 5.5%イタリア: 引用元論文 551 件、この内訳の 4.8%中国: 引用元論文 540 件、この内訳の 4.7%フランス: 引用元論文 534 件、この内訳の 4.7%オランダ: 引用元論文 497 件、この内訳の 4.3%オーストラリア: 引用元論文 439 件、この内訳の 3.8%ベルギー: 引用元論文 304 件、この内訳の 2.7%スペイン: 引用元論文 302 件、この内訳の 2.6%スイス: 引用元論文 292 件、この内訳の 2.6%
0%21.9%その他 25.4%

分野

  • Medicine74.5%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Physics and Astronomy5.3%
  • Computer Science1.5%
  • Immunology and Microbiology1%
  • Engineering0.9%
  • その他3.1%

トピック

  • Prostate Cancer Treatment and Research15.3%
  • Prostate Cancer Diagnosis and Treatment12.5%
  • Advanced Radiotherapy Techniques5.5%
  • Radiopharmaceutical Chemistry and Applications2.7%
  • Cancer, Lipids, and Metabolism2.4%
  • Cancer Genomics and Diagnostics1.8%
  • その他59.8%

共著者

全論文

検索で開く
  1. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter Hoskin, J.F. Lester, Zafar Malik, Fiona McKinna, Neil McPhail, Julian Money‐Kyrle, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Carys Thomas, John Wagstaff, James Wylie, Anjali Zarkar, Mahesh Parmar, Matthew R. Sydes - New England Journal of Medicine 2017 被引用: 1,772

  2. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Hughes, Robert Laing, Fiona McKinna, Duncan B. McLaren, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Angus Robinson, Narayanan Srihari, Rajaguru Srinivasan, John Staffurth, Santhanam Sundar, Shaun Tolan, David Tsang, John Wagstaff, Mahesh Parmar - The Lancet 2015 被引用: 1,968

  3. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sai Jonnada, Sara Khaksar, J.F. Lester, Joe M. O’Sullivan, Omi Parikh, Ian Pedley, Delia Pudney, D.J. Sheehan, Narayanan Srihari, Anna Tran, Mahesh Parmar, Matthew R. Sydes - The Lancet 2018 被引用: 1,262

  4. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 被引用: 1,317

  5. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mymoona Alzoueb, Omi Parikh, Angus Robinson, Isabel Syndikus, James Wylie, Anjali Zarkar, George Thalmann, Johann S de Bono, David P Dearnaley, Malcolm D Mason, Duncan Gilbert, Ruth E Langley, Robin Millman, David Matheson, Matthew R Sydes, Louise C Brown, Mahesh K B Parmar, Nicholas D James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, Dakshinamoorthy Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, Mohammed Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry Taylor, John Graham, Carla Perna, Lucinda Melcher, Warren Grant, Katherine Hyde, Ami Sabharwal, Uschi Hofmann, Robert Dealey ほか 73 名 - The Lancet 2021 被引用: 367

  6. Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joanna Gale, Stephanie Gibbs, Anna Lydon, Ashok Nikapota, Aurelius Omlin, Joe M. O’Sullivan, Omi Parikh, Andrew Protheroe, Sarah Rudman, Narayanan Srihari, Matthew Simms, Jacob Tanguay, Shaun Tolan, John Wagstaff, Jan Wallace, J. Wylie, Anjali Zarkar, Matthew R. Sydes, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2019 被引用: 398

  7. Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy

    著者: , , , , , , , , - Clinical Cancer Research 2019 被引用: 195

  8. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Narayanan Srihari, Carys Thomas, Jacob Tanguay, John Wagstaff, Prantik Das, Emma Gray, Mymoona Alzouebi, Omi Parikh, Angus Robinson, Amir Montazeri, James Wylie, Anjali Zarkar, Richard Cathomas, Michael D. Brown, Yatin Jain, David P. Dearnaley, Malcolm D. Mason, Duncan C. Gilbert, Ruth E. Langley, Robin Millman, David Matheson, Matthew R. Sydes, Louise Brown, Mahesh Parmar, Nicholas D. James, Elin Jones, Katherine Hyde, Hilary Glen, Sarah Needleman, Ursula McGovern, Denise Sheehan, Sangeeta Paisey, Richard Shaffer, Mark Beresford, Zafar Malik, Anjali Zarkar, Emilio Porfiri, David Fackrell, Ling Lee, Thiagarajan Sreenivasan, Sue Brock, Simon Brown, Amit Bahl, Mike Smith-Howell, Cathryn Woodward, Mau-Don Phan, Danish Mazhar, Krishna Narahari, Jacob Tanguay, Fiona Douglas, Anil Kumar, Abdel Hamid, Azman Ibrahim, D. Muthukumar, Matthew Simms, Jane Worlding, Anna Tran, M. Kagzi, Prantik Das, Carmel Pezaro, Virgil Sivoglo, Benjamin Masters, Pek Keng-Koh, Caroline Manetta, Duncan B. McLaren, Nishi Gupta, Denise Sheehan, Stergios Boussios, Henry M. Taylor, John D. Graham ほか 80 名 - The Lancet Oncology 2023 被引用: 102

  9. Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel Ford, Joanna Gale, Ann Henry, Peter Hoskin, M. Kagzi, Anna Lydon, Joe M. O’Sullivan, Sangeeta Paisey, Omi Parikh, Delia Pudney, Vijay Ramani, Peter Robson, Narayanan Srihari, Jacob Tanguay, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trial Collaborative Group - PLoS Medicine 2022 被引用: 121

  10. PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2014 被引用: 258

  11. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Prantik Das, Dan Ford, Joanna Gale, Warren Grant, Emma Gray, Peter Hoskin, Mohammad Muneeb Khan, Caroline Manetta, Neil McPhail, Joe M. O’Sullivan, Omi Parikh, Carla Perna, Carmel Pezaro, Andrew Protheroe, Angus Robinson, Sarah Maria Rudman, D.J. Sheehan, Narayanan Srihari, Isabel Syndikus, Jacob Tanguay, Carys Thomas, Salil Vengalil, John Wagstaff, James Wylie, Mahesh Parmar, Matthew R. Sydes, for the STAMPEDE Trials Collaborative Group - International Journal of Cancer 2022 被引用: 77

  12. Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - European Urology 2019 被引用: 205

  13. Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , - JAMA Oncology 2021 被引用: 137

  14. Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 497

  15. Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pete Shiarly, Joanna Thorn, Sean Harrison, Luke Hounsome, Charlotte Davies, Laura Hughes, Mari‐Anne Rowlands, Lindsey Bell, Elizabeth Hill, Siaw Yein Ng, Naomi Williams, Jessica Toole, Michael Baum, Tracy Roberts, Mary Robinson, David P. Dearnaley, Fritz H. Schröder, T. J. Peters, Teresa Lennon, Sue Bonnington, Lars Holmberg, Robert Pickard, Simon G. Thompson, Usha Menon, Jon McFarlane, Richard J. Bryant, John Dormer, Colette Reid, Amit Bahl, Anthony Koupparis, David Gunnell - JAMA 2024 被引用: 95

  16. NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2020 被引用: 140

  17. Stereotactic body radiotherapy for oligometastases

    著者: , , , , , , , , , - The Lancet Oncology 2012 被引用: 529

  18. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 被引用: 462

  19. Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    著者: , , , , , , , , , , , , , , , , , , , - European Urology 2014 被引用: 436

  20. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning

    著者: , , , , , - Radiotherapy and Oncology 1997 被引用: 321

  21. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Duncan B. McLaren, J.F. Lester, Ashok Nikapota, Joe M. O’Sullivan, Omi Parikh, C. Peedell, Andrew Protheroe, Sarah Maria Rudman, Richard Shaffer, Denise Sheehan, Matthew Simms, Narayanan Srihari, Raeto T. Strebel, Santhanam Sundar, Shaun Tolan, D. Tsang, M. Varughese, John Wagstaff, Mahesh Parmar, Nicholas D. James - Annals of Oncology 2018 被引用: 250

  22. Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 896

  23. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo De Giorgi, Enrique González‐Billalabeitia, Gerhardt Attard - Annals of Oncology 2017 被引用: 269

  24. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist

    著者: , , , - The Lancet Oncology 2014 被引用: 138